Total Payments
$2,926
2024 Payments
$428.99
Companies
28
Transactions
151
Medicare Patients
6,448
Medicare Billing
$235,146
Payment Breakdown by Category
Food & Beverage$2,888 (98.7%)
Education$37.35 (1.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,888 | 148 | 98.7% |
| Education | $37.35 | 3 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $731.09 | 25 | $0 (2024) |
| ABBVIE INC. | $578.77 | 43 | $0 (2024) |
| Amgen Inc. | $276.31 | 12 | $0 (2024) |
| GlaxoSmithKline, LLC. | $158.13 | 5 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $144.94 | 7 | $0 (2022) |
| PFIZER INC. | $140.15 | 10 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $118.25 | 6 | $0 (2024) |
| Abbott Laboratories | $115.28 | 6 | $0 (2024) |
| Allergan Inc. | $81.75 | 1 | $0 (2018) |
| SANOFI PASTEUR INC. | $67.01 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $428.99 | 27 | ABBVIE INC. ($211.80) |
| 2023 | $612.63 | 37 | ABBVIE INC. ($131.45) |
| 2022 | $689.67 | 41 | Novo Nordisk Inc ($182.86) |
| 2021 | $298.03 | 18 | AbbVie Inc. ($67.48) |
| 2020 | $404.26 | 16 | Novo Nordisk Inc ($169.05) |
| 2019 | $195.27 | 8 | GlaxoSmithKline, LLC. ($118.48) |
| 2018 | $198.49 | 3 | Novo Nordisk Inc ($104.84) |
| 2017 | $98.35 | 1 | Novo Nordisk Inc ($98.35) |
All Payment Transactions
151 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/11/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Neuroscience | ||||||
| 10/30/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $34.14 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/28/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: Diabetes Care | ||||||
| 10/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.42 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $10.95 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/03/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $22.51 | General |
| 09/24/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: VACCINES | ||||||
| 08/28/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: Gastroenterology | ||||||
| 08/20/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.24 | General |
| Category: NEUROSCIENCE | ||||||
| 07/18/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $9.60 | General |
| Category: NEUROSCIENCE | ||||||
| 07/08/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/27/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: NEUROSCIENCE | ||||||
| 06/04/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: VACCINES | ||||||
| 05/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: NEUROSCIENCE | ||||||
| 04/11/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Bone Health | ||||||
| 04/01/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $4.50 | General |
| Category: NEUROSCIENCE | ||||||
| 03/26/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $10.96 | General |
| Category: NEUROSCIENCE | ||||||
| 03/19/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, PENBRAYA | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: VACCINES | ||||||
| 03/12/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: Diabetes Care | ||||||
| 03/11/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/14/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: Obesity | ||||||
| 02/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: NEUROSCIENCE | ||||||
| 02/01/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 796 | 932 | $134,773 | $41,886 |
| 2022 | 17 | 1,165 | 1,350 | $147,603 | $42,545 |
| 2021 | 25 | 2,273 | 2,893 | $204,124 | $84,599 |
| 2020 | 25 | 2,214 | 2,838 | $170,853 | $66,116 |
Total Patients
6,448
Total Services
8,013
Medicare Billing
$235,146
Procedure Codes
78
All Medicare Procedures & Services
78 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 184 | 272 | $47,645 | $11,420 | 24.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 201 | 201 | $46,160 | $8,911 | 19.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 136 | 172 | $21,500 | $6,696 | 31.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 80 | 80 | $6,000 | $5,741 | 95.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 17 | 17 | $4,760 | $4,665 | 98.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 80 | 80 | $2,400 | $2,349 | 97.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 13 | 13 | $2,990 | $856.43 | 28.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 25 | 25 | $750.00 | $734.00 | 97.9% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 37 | 48 | $2,256 | $456.96 | 20.3% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 12 | 12 | $120.00 | $30.87 | 25.7% |
| 81003 | Automated urinalysis test | Office | 2023 | 11 | 12 | $192.00 | $26.40 | 13.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 199 | 320 | $56,235 | $13,932 | 24.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 196 | 196 | $44,970 | $8,732 | 19.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 113 | 141 | $17,625 | $5,889 | 33.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 77 | 77 | $5,775 | $5,278 | 91.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 79 | 80 | $2,400 | $2,238 | 93.3% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 15 | 15 | $1,915 | $1,883 | 98.3% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 21 | 21 | $4,830 | $1,183 | 24.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 83 | 87 | $4,089 | $673.19 | 16.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 20 | 20 | $600.00 | $560.98 | 93.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 158 | 185 | $2,035 | $552.66 | 27.2% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 22 | 22 | $1,474 | $369.43 | 25.1% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 25 | 25 | $1,450 | $334.49 | 23.1% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 28 | 31 | $1,457 | $299.77 | 20.6% |
| 83721 | Ldl cholesterol level | Office | 2022 | 25 | 25 | $750.00 | $262.28 | 35.0% |
About Dr. Kathryn Karhoff, DO
Dr. Kathryn Karhoff, DO is a Family Medicine healthcare provider based in Findlay, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/27/2010. The National Provider Identifier (NPI) number assigned to this provider is 1972822153.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kathryn Karhoff, DO has received a total of $2,926 in payments from pharmaceutical and medical device companies, with $428.99 received in 2024. These payments were reported across 151 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($2,888).
As a Medicare-enrolled provider, Karhoff has provided services to 6,448 Medicare beneficiaries, totaling 8,013 services with total Medicare billing of $235,146. Data is available for 4 years (2020–2023), covering 78 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Findlay, OH
- Active Since 05/27/2010
- Last Updated 07/02/2018
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1972822153
Products in Payments
- Saxenda (Drug) $392.39
- EVENITY (Biological) $262.42
- UBRELVY (Drug) $191.45
- LINZESS (Drug) $191.01
- JARDIANCE (Drug) $150.99
- TRELEGY ELLIPTA (Drug) $143.03
- VRAYLAR (Drug) $135.30
- XIFAXAN (Drug) $118.25
- QULIPTA (Drug) $100.76
- Victoza (Drug) $98.35
- FREESTYLE LIBRE 3 (Device) $66.71
- NURTEC ODT (Drug) $64.12
- Ozempic (Drug) $61.56
- PREVNAR 13 (Biological) $50.67
- Tresiba (Drug) $49.09
- FARXIGA (Drug) $43.26
- PREVNAR 20 (Biological) $41.01
- Livalo (Drug) $39.45
- ELIQUIS (Drug) $37.35
- Wegovy (Drug) $31.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Findlay
Dr. Thomas Grace, M.d, M.D
Family Medicine — Payments: $441,282
Family Medicine $441,282
Dr. Scott Rioch, D.o, D.O
Family Medicine — Payments: $18,175
Family Medicine $18,175
Dr. David Ware, M.d, M.D
Family Medicine — Payments: $5,341
Family Medicine $5,341
Dr. Donald Johnson, D.o, D.O
Family Medicine — Payments: $1,730
Family Medicine $1,730
Dr. William Hopkins, M.d, M.D
Family Medicine — Payments: $1,727
Family Medicine $1,727
Michael Manuel, M.d, M.D
Family Medicine — Payments: $1,361
Family Medicine $1,361